Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zamani (Konya, Turkey), A. Zamani (Konya, Turkey), C. Korkmaz (Konya, Turkey), S. Yosunkaya (Konya, Turkey), M. Yildirim (Konya, Turkey). Variants  of genes related to cardiovascular disease in patients with pulmonary thromboembolism. 3800

Member's Comments

No comment yet.

Related content which might interest you: Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Factors associated with thromboembolic events in patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J 2014; 44: 951-962 Year: 2014 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Association of clinical features with HLA in chronic pulmonary thromboembolism Source: Eur Respir J 2005; 25: 131-138 Year: 2005 Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Analysis of risk factors in pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018